Wiley, one of the world's largest publishers and a global leader in research and learning, today announced the 2025 release of its Wiley Identifier of Natural Products (AntiBase Library + ChemWindow).
Scientists have discovered a naturally-occurring molecule that rivals the weight-loss effects of semaglutide-based GLP-1s like Ozempic in animals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback